Vanguard Global Advisers
SRTA

Vanguard Global Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Vanguard Global Advisers’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Hold
24,434
– – ﹤0.01% 2681
2026
Q1 		$102K Buy
+24,434
New +$118K ﹤0.01% 2718

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's SRTA Position: Q2 2026 in Review

Vanguard Global Advisers held its Strata Critical Medical Inc (SRTA) position steady in Q2 2026 at 24,434 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Vanguard Global Advisers first reported a position in SRTA in Q1 2026 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Vanguard Global Advisers held 24,434 shares of Strata Critical Medical Inc worth $129K as of Q2 2026.
  • Vanguard Global Advisers left its Strata Critical Medical Inc share count unchanged in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2681 holding.
  • Vanguard Global Advisers first reported a position in Strata Critical Medical Inc in Q1 2026 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.